Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Last updated on: 16-05-2026 See affordable match Delivery by
intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 Centers for Disease Control and Prevention
Originally characterized by the Sikiric group at the University of Zagreb School of Medicine, BPC-157 is unusual among peptides for its reported oral activity attributed to its origin in gastric juice, which suggests evolutionary adaptation to the digestive environment
As an analogue of amylin, it is designed to be more stable and long-acting, overcoming some of the limitations of the natural peptide ( 6, 7 )
US$ 21.41
US$ 23.92
US$ 27.43
US$ 25.04
US$ 26.58
US$ 22.07
US$ 21.50
US$ 27.69
